Efficacy and safety of fixed-dose clindamycin phosphate 1.2%/adapalene 0.15%/benzoyl peroxide 3.1% gel in Hispanic participants with moderate-to-severe acne: a pooled analysis

Efficacy and safety of fixed-dose clindamycin phosphate 1.2%/adapalene 0.15%/benzoyl peroxide 3.1% gel in Hispanic participants with moderate-to-severe acne: a pooled analysis

Introduction Clindamycin phosphate 1.2%/adapalene 0.15%/benzoyl peroxide 3.1% (CAB) gel is the only fixed-dose, triple-combination approved for acne. In phase 2 and 3 studies, CAB demonstrated superior efficacy to vehicle and component dyads. This post hoc analysis examined efficacy/tolerability of...

Full description

Saved in:
Bibliographic Details
Main Authors: Valerie D. Callender, Hilary Baldwin, Linda Stein Gold, Fran E. Cook-Bolden, Eric Guenin, Andrew F. Alexis
Format: Article
Language:English
Published: Taylor & Francis Group 2025-12-01
Series:Journal of Dermatological Treatment
Subjects:
Antibiotic
antimicrobial
skin of color
Latino
retinoid
topical
Online Access:https://www.tandfonline.com/doi/10.1080/09546634.2025.2480232
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items